Enquiry/Quote

Respiratory Disorder

Trusted pharma products in Respiratory Disorder

Levodropropizine

Strength: 60mg , 30mg/5ml

Form: Tablets / Syrups

Reference Brands: Levopront, Levare

View Details Get Enquiry

Levofloxacin

Strength: Tab: 250 mg, 500 mg, 750 mg; Oral Solution: 25 mg/mL

Form: Tablets & Oral Solution

Reference Brands: Levaquin®(US & EU); Tavanic®(EU)

View Details Get Enquiry

Levofloxacin

Strength: 250 mg/50 mL, 500 mg/100 mL, 750 mg/150 mL

Form: IV Infusion

Reference Brands: Levaquin®(US & EU); Tavanic®(EU)

View Details Get Enquiry

Levosalbutamol

Strength: 0.31 mg/3 mL, 0.63 mg/3 mL, and 1.25 mg/3 mL.

Form: Inhalation Solution

Reference Brands: Xopenex®(US), Levolin Respules(India)

View Details Get Enquiry

Mannitol

Strength: 40mg

Form: inhalation powder capsules

Reference Brands: Bronchitol (USA/EU)

View Details Get Enquiry

Mepolizumab

Strength: 100 mg/1 mL

Form: injection (prefilled syringe)

Reference Brands: Nucala (USA/EU)

View Details Get Enquiry

Mometasone + Formoterol

Strength: 100 mcg/5 mcg , 200 mcg/5 mcg

Form: Inhaler(MDI)

Reference Brands: Dulera®(US)

View Details Get Enquiry

Moxifloxacin

Strength: Tab- 400 mg; Opthalmic solution- 0.5% (5 mg/mL)

Form: Tablets & Opthalmic solution

Reference Brands: Avelox®, Avalox®(EU); Avelox®, Vigamox®(US)

View Details Get Enquiry

Moxifloxacin

Strength: 400 mg/250 mL

Form: IV Infusion

Reference Brands: Avelox®, Avalox®(EU); Avelox®, Vigamox®(US)

View Details Get Enquiry

N-acetylcysteine + acebrophylline

Strength: Capsules 7 Tab: N-Acetylcysteine(600 mg) + Acebrophylline(100 mg); Syrup: 100 mg+ 50 mg

Form: Tablets, capsules, syrup

Reference Brands: Respiract, Ascoril LS-AX, Acebryl-N, Nacbro, Brio-Nac(India & others)

View Details Get Enquiry

N-ACETYLCYSTEINE,ACEBROPHYLLINE

Strength: 600mg, 100 mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Nerandomilast

Strength: 10 mg

Form: Tablets

Reference Brands: Jascayd (USA/EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.